搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
contemporarypediatrics
1 天
Marina Z. Joel, BS, MS2
Screening for diabetes in primary care and CGM, AID advice for providers ...
contemporarypediatrics
1 天
Ankita Prasad, DO
Screening for diabetes in primary care and CGM, AID advice for providers ...
contemporarypediatrics
2 天
Rachel S Dawson, DO, MPH, FAAP, FSAHM
Keeping up with type 1 diabetes technology changes in primary care ...
contemporarypediatrics
2 天
Todd A Mahr, MD
Keeping up with type 1 diabetes technology changes in primary care ...
contemporarypediatrics
2 天
Giridhar Guntreddi, MD
Keeping up with type 1 diabetes technology changes in primary care ...
contemporarypediatrics
3 天
Barton Schmitt, MD, FAAP
Keeping up with type 1 diabetes technology changes in primary care ...
contemporarypediatrics
3 天
Janine A. Rethy, MD, MPH
Keeping up with type 1 diabetes technology changes in primary care ...
contemporarypediatrics
3 天
Colleen Wardell, OMA, BA
Keeping up with type 1 diabetes technology changes in primary care ...
contemporarypediatrics
3 天
David Hall, MD
Keeping up with type 1 diabetes technology changes in primary care ...
contemporarypediatrics
4 天
Discussing atopic dermatitis, roflumilast cream 0.15% with Russell Libby, MD, FAAP
Russell Libby, MD, FAAP highlights some key benefits of roflumilast 0.15%, approved in 2024 to treat AD in patients aged 6 years and older. Atopic dermatitis (AD) remains a persistent challenge for ...
contemporarypediatrics
3 天
Matthew L. Lorenz, MD
Keeping up with type 1 diabetes technology changes in primary care ...
contemporarypediatrics
4 天
Lynn Smitherman, MD
Keeping up with type 1 diabetes technology changes in primary care ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈